Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) Cost of Revenue (2012 - 2026)

Iqvia Holdings' (IQV) quarterly Cost of Revenue came in at $2.9 billion in Q2 2026, up 8.87% year-over-year from $2.7 billion in Q2 2025, and up 4.9% quarter-over-quarter from $2.8 billion in Q1 2026.

Analysis

Iqvia Holdings (IQV) Cost of Revenue (2012 - 2026) Analysis & Trends

Iqvia Holdings has disclosed Cost of Revenue across 15 years of filings, most recently posting $2.9 billion for Q2 2026.

  • In Q2 2026, Cost of Revenue rose 8.87% year-over-year to $2.9 billion; the TTM figure through Jun 2026 stood at $11.4 billion (up 10.28% YoY), while the FY2025 annual figure was $10.9 billion, up 8.47% from the prior year.
  • Cost of Revenue came in at $2.9 billion for Q2 2026 at Iqvia Holdings, up from $2.8 billion in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $2.9 billion in Q2 2026 to a low of $2.3 billion in Q3 2022.
  • Average Cost of Revenue over 5 years is $2.5 billion, with a median of $2.5 billion recorded in 2023.
  • Year-over-year, Cost of Revenue advanced 0.34% in 2022 and gained 13.49% in 2025.
  • Over 5 years, Cost of Revenue stood at $2.4 billion in 2022, then gained by 2.95% to $2.5 billion in 2023, then grew by 4.12% to $2.6 billion in 2024, then increased by 13.49% to $2.9 billion in 2025, then climbed by 0.17% to $2.9 billion in 2026.
  • Per Business Quant data, the three most recent Cost of Revenue figures were $2.9 billion in Q2 2026, $2.8 billion in Q1 2026, and $2.9 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 2.93 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 505.69 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 1.58 Bn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 552.01 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 539.00 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 1.72 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 7.53 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn 1.14 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.93 Bn
Mar 31, 2026 2.80 Bn
Dec 31, 2025 2.93 Bn
Sep 30, 2025 2.73 Bn
Jun 30, 2025 2.69 Bn
Mar 31, 2025 2.53 Bn
Dec 31, 2024 2.58 Bn
Sep 30, 2024 2.52 Bn
Jun 30, 2024 2.49 Bn
Mar 31, 2024 2.44 Bn
Dec 31, 2023 2.48 Bn
Sep 30, 2023 2.43 Bn
Jun 30, 2023 2.44 Bn
Mar 31, 2023 2.40 Bn
Dec 31, 2022 2.41 Bn
Sep 30, 2022 2.32 Bn
Jun 30, 2022 2.33 Bn
Mar 31, 2022 2.32 Bn
Dec 31, 2021 2.36 Bn
Sep 30, 2021 2.25 Bn